EDELMAN JOSEPH

Average Profitability
2.81%
Insider Buys Quantity
98
Insider Buys Sum
$176.82M
Insider Sells Quantity
9
Insider Sells Sum
$16.17M

Insider Activity of EDELMAN JOSEPH

The largest purchase of all time was on 2020-09-22 and amounted to 2117648 shares of Athira Pharma, Inc. for $36M.

The largest sale of all time was on 2004-12-03 and amounted to 1395000 shares of ANI Pharmaceuticals, Inc. for $6.56M.

Biography of EDELMAN JOSEPH

No biography is available at this moment.

2022-08-09PurchaseAldeyra Therapeutics, Inc.
ALDX
15,000
0.027%
$7.85$117,750-4.83%
2022-08-08PurchaseAldeyra Therapeutics, Inc.
ALDX
97,000
0.1669%
$7.24$702,280-1.53%
2022-08-05PurchaseAldeyra Therapeutics, Inc.
ALDX
141,000
0.2422%
$6.95$979,950+2.46%
2022-08-04PurchaseAldeyra Therapeutics, Inc.
ALDX
95,100
0.1609%
$6.17$586,767+13.46%
2022-08-03PurchaseAldeyra Therapeutics, Inc.
ALDX
100,000
0.1722%
$5.84$584,000+21.64%
2022-08-02PurchaseAldeyra Therapeutics, Inc.
ALDX
412,406
0.6992%
$5.59$2.31M+24.82%
2022-08-01PurchaseAldeyra Therapeutics, Inc.
ALDX
144,185
0.2447%
$5.05$728,134+38.21%
2022-07-29PurchaseAldeyra Therapeutics, Inc.
ALDX
222,123
0.3792%
$5.03$1.12M+39.29%
2022-07-28PurchaseAldeyra Therapeutics, Inc.
ALDX
119,392
0.2042%
$5.00$596,960+40.1%
2022-07-05PurchaseVerrica Pharmaceuticals Inc.
VRCA
1.43M
2.9773%
$2.10$3M+61.6%
2022-06-29PurchaseAthira Pharma, Inc.
ATHA
270,000
0.7168%
$2.99$807,300+5.69%
2022-04-18PurchaseCrinetics Pharmaceuticals, Inc.
CRNX
157,515
0.2905%
$22.22$3.5M-18.7%
2022-04-12PurchaseLyra Therapeutics, Inc.
LYRA
5.92M
11.8975%
$4.22$25M-21.89%
2020-09-22PurchaseAthira Pharma, Inc.
ATHA
2.12M
28.5829%
$17.00$36M+11.98%
2008-11-19SaleXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
9.6M
6.44%
$0.15$1.47M+40%
2008-11-18SaleXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
30.45M
19.0502%
$0.14$4.34M+7.69%
2008-06-10PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
51,000
0.7232%
$3.23$164,730-92.26%
2008-06-09PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
33,600
0.4956%
$3.36$112,896-92.63%
2008-06-06PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
100,000
1.5059%
$3.43$343,000-92.84%
2008-06-05PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
300,000
4.2453%
$3.22$967,000-92.75%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.